Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook



 

Embryo gene-editing is unsafe and unethical, say gene-editing scientists

23 March 2015

By Meghna Kataria

Appeared in BioNews 795

Scientists have called for a worldwide moratorium on the use of the gene-editing technique CRISPR/Cas9 in human embryos and germ cells.

A group of biologists, led by the co-discoverer of the technique Jennifer Doudna, say that safety and ethical concerns over the use of the technology in the human germline must be addressed first.

The need for these discussions has taken on a new urgency amid rumours that such experiments are already underway, leading to fears that the technique could be used clinically in countries that lack stringent regulations.

As any germline changes introduced by the technique can be inherited, the researchers say that this crosses an ethical boundary. 'You could exert control over human heredity with this technique, and that is why we are raising the issue,' Dr David Baltimore, former president of California Institute of Technology and one of the authors of the letter published in Science, told the New York Times.

The advent of the CRISPR/Cas9 system has revolutionised the field of genetic engineering (see BioNews 730) – enabling easy and precise alterations of the genetic code. Since its discovery in 2012 it has been used in organisms ranging from yeast and flies to monkeys. And, if reports are true, several papers will be published imminently on its use in human embryos.

'In humans, it holds the promise of curing genetic disease,' write the scientists. However, they caution that despite these rapid developments, we do not understand the risks this technology might pose if used in germ cells or embryos.

'We worry about people making changes without the knowledge of what those changes mean in terms of the overall genome,' said Dr Baltimore. 'I personally think we are just not smart enough - and won’t be for a very long time - to feel comfortable about the consequences of changing heredity, even in a single individual.'

A similar warning is sounded by authors of a second article, published in Nature. They argue that even though CRISPR/Cas9 is lauded for its precision, we do not know if it could cause unforeseen changes in a part of the genome other than the intended gene. Since such 'off-target effects' can be hard to detect, their consequences may only come to light after a baby is born.

Furthermore, they fear gene-editing in embryos could lead to non-therapeutic gene enhancement leading to the creation of so-called 'designer babies'.

Some, however, feel that given its potential, embryo gene-editing should get the go-ahead for research purposes until concerns over human use are worked out.

Nobel Prize-winning geneticist Dr Craig Mello of the University of Massachusetts told Nature: 'In the distant future, I could imagine that altered germ lines would protect humans against cancer, diabetes and other age-related problems.' In the nearer term, he said, 'there could be good reason to experiment with discarded embryos or embryonic stem cells for research purposes'.

SOURCES & REFERENCES
Science | 19 March 2015
 
Nature | 12 March 2015
 
MIT Technology Review | 05 March 2015
 
Nature | 19 March 2015
 
MIT Technology Review | 19 March 2015
 
New York Times | 19 March 2015
 
Nature | 12 March 2015
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

06 July 2015 - by Cait McDonagh 
The US Congress has released a bill that would prohibit the Food and Drug Administration from spending any money in relation to projects that involve editing the human genome...
26 May 2015 - by Ceri Durham 
Scientists will gather in the USA later this year to produce ethical guidelines on the use of human gene-editing techniques such as CRISPR/Cas9....
11 May 2015 - by Dr Calum MacKellar 
The short article by Robin Lovell-Badge entitled 'Editing human embryos' addressing the work of Junjiu Huang and colleagues in China on gene editing in human embryos - such as the use of the CRISPR/Cas9 system - raises a number of ethical questions....
11 May 2015 - by Dr Indrayani Ghangrekar & Ayala Ochert 
Molecular biologists have used gene-editing technology to identify promising targets for anti-cancer drugs...
05 May 2015 - by Dr James Heather 
US researchers have used the CRISPR/Cas9 system to target hepatitis C infection in human cells...

16 February 2015 - by Nina Chohan 
Scientists have shown for the first time that whole-genome sequencing (WGS) in IVF embryos can detect 'de novo' mutations...
02 February 2015 - by Claire Downes 
AstraZeneca has joined up with academic and industrial research partners to use CRISPR, a new and much-hyped gene-editing technology in their quest for new medicines....
02 December 2013 - by Rachel Brown 
A biotech start-up that will develop genome-editing therapies has received US $43 million investment from three venture capital firms...
11 November 2013 - by Dr Anna Cauldwell 
A molecular technique that enables any part of the human genome to be altered with extreme precision has been hailed by scientists as a breakthrough in genetics...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust
Advertise your products and services HERE - click for further details
Become a Friend of PET HERE and give the Progress Educational Trust a regular donation

Good Fundraising Code

Find out more about the Progress Educational Trust by downloading our brochure HERE